Open Orphan Plc Stock Beta
| OPORF Stock | USD 0.09 0.00 0.00% |
As of the 11th of February 2026, Open Orphan holds the Coefficient Of Variation of (812.40), variance of 62.3, and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Open Orphan, as well as the relationship between them. Please check Open Orphan plc coefficient of variation and maximum drawdown to decide if Open Orphan plc is priced some-what accurately, providing market reflects its current price of 0.0861 per share. As Open Orphan plc appears to be a penny stock we also advise to check out its information ratio numbers.
Open Orphan's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Open Orphan's valuation are provided below:Open Orphan plc does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Open |
Open Orphan 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Open Orphan's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Open Orphan.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Open Orphan on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Open Orphan plc or generate 0.0% return on investment in Open Orphan over 90 days. Open Orphan is related to or competes with Silence Therapeutics, Oryzon Genomics, Transgene, Frontage Holdings, Hansa Biopharma, Genfit SA, and Benchmark Holdings. Open Orphan Plc operates as a pharmaceutical service and contract research company More
Open Orphan Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Open Orphan's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Open Orphan plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 64.13 |
Open Orphan Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Open Orphan's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Open Orphan's standard deviation. In reality, there are many statistical measures that can use Open Orphan historical prices to predict the future Open Orphan's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.80) | |||
| Treynor Ratio | 1.12 |
Open Orphan February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 1.13 | |||
| Mean Deviation | 1.91 | |||
| Coefficient Of Variation | (812.40) | |||
| Standard Deviation | 7.89 | |||
| Variance | 62.3 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.80) | |||
| Treynor Ratio | 1.12 | |||
| Maximum Drawdown | 64.13 | |||
| Skewness | (8.12) | |||
| Kurtosis | 66.0 |
Open Orphan plc Backtested Returns
Open Orphan plc maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Open Orphan plc exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Open Orphan's Variance of 62.3, risk adjusted performance of (0.09), and Coefficient Of Variation of (812.40) to confirm the risk estimate we provide. The company holds a Beta of -0.88, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Open Orphan are expected to decrease slowly. On the other hand, during market turmoil, Open Orphan is expected to outperform it slightly. At this point, Open Orphan plc has a negative expected return of -1.03%. Please make sure to check Open Orphan's coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price , to decide if Open Orphan plc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Open Orphan plc has no correlation between past and present. Overlapping area represents the amount of predictability between Open Orphan time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Open Orphan plc price movement. The serial correlation of 0.0 indicates that just 0.0% of current Open Orphan price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Open Orphan plc has a Beta of 1.1697. This is 36.01% higher than that of the Healthcare sector and 15.85% lower than that of the Biotechnology industry. The beta for all United States stocks is notably lower than that of the firm.
Open Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Open Orphan's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Open Orphan could also be used in its relative valuation, which is a method of valuing Open Orphan by comparing valuation metrics of similar companies.Open Orphan is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Open Orphan will likely underperform.
Open Fundamentals
| Return On Equity | -0.05 | |||
| Return On Asset | 0.0066 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 80.15 M | |||
| Shares Outstanding | 671.05 M | |||
| Shares Owned By Insiders | 40.93 % | |||
| Shares Owned By Institutions | 6.45 % | |||
| Price To Book | 2.64 X | |||
| Price To Sales | 2.93 X | |||
| Revenue | 36.86 M | |||
| Gross Profit | 4.29 M | |||
| EBITDA | 3.07 M | |||
| Net Income | (74 K) | |||
| Cash And Equivalents | 15.93 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 2.26 M | |||
| Debt To Equity | 0.11 % | |||
| Current Ratio | 1.19 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (1.56 M) | |||
| Number Of Employees | 218 | |||
| Beta | 1.17 | |||
| Market Capitalization | 96.91 M | |||
| Total Asset | 42.27 M | |||
| Z Score | 25.2 | |||
| Net Asset | 42.27 M |
About Open Orphan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Open Orphan plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Open Orphan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Open Orphan plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Open Pink Sheet
Open Orphan financial ratios help investors to determine whether Open Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Open with respect to the benefits of owning Open Orphan security.